Previous evidence using a human cancer cell line (MCF-7) showed that 17β-estradiol upregulates the mRNA levels of A2A in a dose-dependent manner, an effect that was inhibited by the ER antagonist ICI182780 [24]. The gene discussed is ESR1; the disease is cancer.